Now It’s Asthma Inhalers’ Turn: Boehringer Will Cap Copays, Cut Some List Prices As Pressure Grows

 
• By Cathy Kelly
Inhalers Succeeding Insulins As Target Of Pricing Complaints • Source: Shutterstock

More from Market Access

More from Pink Sheet